We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.78B
AUM Growth
-$2.15B
Cap. Flow
-$2.29B
Cap. Flow %
-60.64%
Top 10 Hldgs %
32.15%
Holding
6,174
New
508
Increased
1,418
Reduced
3,468
Closed
480

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$269M
2
SMCI icon
Super Micro Computer
SMCI
+$220M
3
SPXL icon
Direxion Daily S&P 500 Bull 3x ETF
SPXL
+$68M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$61M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$215M
2
MSFT icon
Microsoft
MSFT
+$203M
3
NVDA icon
NVIDIA
NVDA
+$156M
4
AMZN icon
Amazon
AMZN
+$119M
5
META icon
Meta Platforms (Facebook)
META
+$97.9M

Sector Composition

Rank Sector Weight
1 Technology 21.67%
2 Financials 9.06%
3 Consumer Discretionary 7.38%
4 Healthcare 7.08%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WEYS icon
3126
Weyco Group
WEYS
$434M
$24.4K ﹤0.01%
716
-1,538
-68% -$50.1K
RAIL icon
3127
FreightCar America
RAIL
$244M
$24.4K ﹤0.01%
2,257
-1,319
-37% -$7.69K
IEFA icon
3128
iShares Core MSCI EAFE ETF
IEFA
$196B
$24.4K ﹤0.01%
312
+258
+478% +$19.3K
VONG icon
3129
Vanguard Russell 1000 Growth ETF
VONG
$46.2B
$24.3K ﹤0.01%
252
+51
+25% +$4.76K
HDSN
3130
Hudson Technologies
HDSN
$238M
$24.3K ﹤0.01%
2,916
-3,958
-58% -$32.7K
NVEE
3131
DELISTED
NV5 Global
NVEE
$24.3K ﹤0.01%
1,040
-13,824
-93% -$329K
RMTI icon
3132
Rockwell Medical
RMTI
$30.3M
$24.2K ﹤0.01%
611
-986
-62% -$26.5K
MRNS
3133
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$24.2K ﹤0.01%
13,765
-5,752
-29% -$8.03K
ATRC icon
3134
AtriCure
ATRC
$2.21B
$24.2K ﹤0.01%
863
-8,008
-90% -$197K
FATE icon
3135
Fate Therapeutics
FATE
$296M
$24.1K ﹤0.01%
6,885
-15,232
-69% -$59.3K
BBN icon
3136
BlackRock Taxable Municipal Bond Trust
BBN
$981M
$24.1K ﹤0.01%
1,352
+1,346
+22,433% +$23.3K
AURA icon
3137
Aura Biosciences
AURA
$791M
$24K ﹤0.01%
2,699
-1,983
-42% -$17K
EQX icon
3138
Equinox Gold
EQX
$13.6B
$24K ﹤0.01%
3,943
-374
-9% -$2.11K
JJSF icon
3139
J&J Snack Foods
JJSF
$1.69B
$23.9K ﹤0.01%
139
-2,168
-94% -$364K
CVRX icon
3140
CVRx
CVRX
$79.9M
$23.9K ﹤0.01%
2,714
+368
+16% +$3.35K
FRBA icon
3141
First Bank
FRBA
$471M
$23.9K ﹤0.01%
1,571
-1,107
-41% -$16.1K
SLNO
3142
DELISTED
Soleno Therapeutics
SLNO
$23.8K ﹤0.01%
472
-7,581
-94% -$363K
ATYR
3143
aTyr Pharma
ATYR
$54.9M
$23.8K ﹤0.01%
13,540
-13,798
-50% -$25.1K
CLMT icon
3144
Calumet Specialty Products
CLMT
$4.27B
$23.8K ﹤0.01%
+1,336
New +$21.4K
BOTZ icon
3145
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.59B
$23.8K ﹤0.01%
739
+7
+1% +$214
EMQQ icon
3146
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$270M
$23.7K ﹤0.01%
605
-30
-5% -$1.02K
ORKA
3147
Oruka Therapeutics
ORKA
$6.96B
$23.7K ﹤0.01%
965
+936
+3,228% +$32.6K
IMKTA icon
3148
Ingles Markets
IMKTA
$1.66B
$23.6K ﹤0.01%
316
-1,168
-79% -$85.9K
ARDX icon
3149
Ardelyx
ARDX
$1B
$23.5K ﹤0.01%
3,408
-23,937
-88% -$141K
VET icon
3150
Vermilion Energy
VET
$1.73B
$23.5K ﹤0.01%
2,402
-4,832
-67% -$49K
124 125
126
127 128

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2024 Portfolio in Review

As of Q3 2024, Tower Research Capital (TRC) held 6,174 positions worth $3.78B, down 36% from $5.92B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.29B in Q3 2024, closing 480 positions and reducing 3,468 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $9.26M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares US Technology ETF worth $6.83M.

  • Tower Research Capital (TRC)'s largest Q3 2024 buy was iShares US Technology ETF: 45,025 shares worth $6.83M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q3 2024, an estimated $269M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2024 reduction was Apple, cutting an estimated $215M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2024, selling an estimated $9.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.78B portfolio in Q3 2024.
  • Tower Research Capital (TRC) opened 508 new positions and closed 480 in Q3 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $3.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.